Literature DB >> 1421799

Corticosteroid-induced osteoporosis: effects of a treatment with slow-release sodium fluoride.

M Greenwald1, D Brandli, S Spector, S Silverman, G Golde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1421799     DOI： 10.1007/bf01623187

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  4 in total

1.  Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures.

Authors:  C Y Pak; K Sakhaee; J E Zerwekh; C Parcel; R Peterson; K Johnson
Journal:  J Clin Endocrinol Metab       Date:  1989-01       Impact factor: 5.958

Review 2.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

3.  The long-term treatment of steroid osteoporosis with fluoride.

Authors:  T A Bayley; C Muller; J Harrison; J Basualdo; W Sturtridge; R Josse; T M Murray; K P Pritzker; R Vieth; S Goodwin
Journal:  J Bone Miner Res       Date:  1990-03       Impact factor: 6.741

4.  Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis.

Authors:  N Mamelle; P J Meunier; R Dusan; M Guillaume; J L Martin; A Gaucher; A Prost; G Zeigler; P Netter
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321
  4 in total
  8 in total

1.  Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis?

Authors:  W F Lems; J W Jacobs; J W Bijlsma; G J van Veen; H H Houben; H C Haanen; M I Gerrits; H J van Rijn
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

Review 2.  Prevention and treatment of glucocorticoid-induced osteoporosis.

Authors:  F Eggelmeijer
Journal:  Pharm World Sci       Date:  1998-10

3.  Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis.

Authors:  W F Lems; W G Jacobs; J W Bijlsma; A Croone; H C Haanen; H H Houben; M I Gerrits; H J van Rijn
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study.

Authors:  G Guaydier-Souquières; P O Kotzki; J P Sabatier; B Basse-Cathalinat; G Loeb
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

Review 5.  Corticosteroid-induced bone loss. Prevention and management.

Authors:  C Picado; M Luengo
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

6.  Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate.

Authors:  E Meys; F Terreaux-Duvert; T Beaume-Six; G Dureau; P J Meunier
Journal:  Osteoporos Int       Date:  1993-12       Impact factor: 4.507

7.  Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticosteroid-induced osteoporosis.

Authors:  R Rizzoli; T Chevalley; D O Slosman; J P Bonjour
Journal:  Osteoporos Int       Date:  1995-01       Impact factor: 4.507

Review 8.  Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.

Authors:  Albrecht W Popp; Juerg Isenegger; Elizabeth M Buergi; Ulrich Buergi; Kurt Lippuner
Journal:  Eur Spine J       Date:  2006-07       Impact factor: 3.134
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.